Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP Cisplatin + Gemcitabine + Nab-paclitaxel in Pancreatic Cancer with Peritoneal Metastasis
NCT05222204Phase 2Completed
- Sponsor
- Fudan University
- Start
- May 2022
- Primary completion
- Jul 2024
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in pancreatic cancer (PC), sponsored by Fudan University. Started May 2022; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT05222204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05222204.